This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

8 Undervalued Stocks Getting Help From the U.S.

8. Occidental Petroleum (OXY)

Company profile: Occidental, with a market value of $72 billion, is one of the largest oil and gas companies in the U.S., although it has global exploration and production operations. Its subsidiary, OxyChem, is one of the biggest marketers of chlorine and caustic soda. U.S. sales made up 63% of 2011's sales, followed by the Middle East and North Africa, at 33%.

Dividend Yield:2.43%. Note that Occidental has raised its dividend every year since 2002.

Investor takeaway: Its shares are down 5% this year, but have a three-year, average annual return of 9%. Analysts give its shares 11 "buy" ratings, five "buy/holds," and six "holds," according to a survey of analysts by S&P. S&P has it rated "buy" with a $104 price target, which is a 17% premium to the current price.

Morningstar analyst Allen Good wrote last week that while the company reported lower second-quarter earnings of $1.3 billion versus $1.8 billion last year (due primarily to lower oil and natural gas prices), it is making progress in "getting its operations on track and driving volume growth, particularly in the U.S.," which has been a recent focus.

7. WellPoint (WLP)

Company profile: WellPoint, with a market value of $18 billion, is the largest managed health organization in the U.S. It offers various network-based managed care plans to large and small employers, individuals, and Medicaid programs.

Dividend Yield: 2.1%

Investor takeaway: Its shares are up 11% this year and have a three-year, average annual return of 7.4%. Analysts give its shares seven "buy" ratings, four "buy/holds," and nine "holds," according to a survey of analysts by S&P.

S&P has it rated "buy" with a 12-month price target of $68, a 26% premium to the current price. For fiscal year 2012, analysts' consensus earnings estimate is for $7.38 per share and growth of 12% to $8.24 per share next year.

6. Walgreen (WAG)

Company profile: Walgreen, with a market value of $31 billion, is the largest U.S. retail drug chain in terms of revenue, and owns more than 8,000 drug stores throughout the U.S. The Fidelity Mega-Cap Fund has been a recent buyer.

Dividend Yield: 2.48%

Investor takeaway: Its shares are up 11% this year and have a three-year, average annual return of 7.4%. Analysts give its shares four "buy" ratings, five "buy/holds," 12 "holds," one "weak hold," and three "sells," according to a survey of analysts by S&P.

Analysts' consensus estimate if for earnings of $2.60 per share this year, and $3.01 next year, or 16% growth. It's seen as benefiting from the aging populace and its need for more prescriptions, but is in a highly competitive and consolidating industry, which could hurt its sales in the long run.

5. Time Warner (TWX)

Company profile: Time Warner, with a market value of $38 billion, owns some of the world's leading media and entertainment brands, including Warner Bros. (film/TV studio), Turner cable networks (TNT, TBS, CNN), the HBO/Cinemax premium channels, as well as several magazine brands through its Time Inc. publishing businesses. It generates about 30% of sales from outside the U.S.

Dividend Yield: 2.63%

Investor takeaway: Its shares are up 11% this year and have a three-year, average annual return of 19%. Analysts give its shares 11 "buy" ratings, 12 "buy/holds," and nine "holds," according to a survey of analysts by S&P.

Analysts' consensus estimate is for earnings of $3.20 per share this year and $3.63 next year, or 13% growth. S&P has it rated "buy" with a $44 price target, which is an 8% premium to its current price.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
TW $129.73 0.62%
CMCSK $55.69 -1.10%
MCK $226.04 0.23%
TGT $80.50 -1.40%
WFC $54.50 -0.06%

Markets

DOW 17,686.97 -31.57 -0.18%
S&P 500 2,057.56 -3.49 -0.17%
NASDAQ 4,865.6680 -10.8510 -0.22%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs